Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases
Vaccinations are necessary for individuals on immunotherapy to reduce the risk of infections and the associated risk of worsening neurological autoimmune diseases. However, the humoral and cellular vaccination response may be impaired under immunotherapy necessitating close monitoring. Here, we provide applicable recommendations to optimize immunization for individuals receiving immunotherapy due to a neurological autoimmune disease.
Authors
- Brigitte Wildemann (ORCID: https://orcid.org/0000-0002-5389-3338)
- Luisa Klotz (ORCID: https://orcid.org/0000-0001-5439-9633)
- Jan D. Lünemann (ORCID: https://orcid.org/0000-0002-3007-708X)
- Achim Berthele (ORCID: https://orcid.org/0000-0001-9650-6222)
- Tania Kümpfel (ORCID: https://orcid.org/0000-0001-7509-5268)
- Hayrettin Tumani (ORCID: https://orcid.org/0000-0002-1647-6201)
- Bernhard Hemmer (ORCID: https://orcid.org/0000-0001-5985-6784)
- Aiden Haghikia (ORCID: https://orcid.org/0000-0001-9629-3298)
- Tobias Brummer (ORCID: https://orcid.org/0000-0002-7887-7211)
- Heinz Wiendl (ORCID: https://orcid.org/0000-0003-4310-3432)
- Anke Salmen (ORCID: https://orcid.org/0000-0002-4751-299X)
- Stefan Bittner (ORCID: https://orcid.org/0000-0003-2179-3655)
- Tobias Ruck (ORCID: https://orcid.org/0000-0001-6332-8650)
- Uwe K. Zettl (ORCID: https://orcid.org/0000-0002-6348-1759)
- Falk Steffen (ORCID: https://orcid.org/0000-0003-3708-8600)
- Felix Luessi (ORCID: https://orcid.org/0000-0003-4334-4199)
- Maria Protopapa (ORCID: https://orcid.org/0009-0000-7707-9050)
- Timo Uphaus (ORCID: https://orcid.org/0000-0001-5526-0510)
- Hans‐Peter Hartung (ORCID: https://orcid.org/0000-0002-0614-6989)
- Thomas Korn (ORCID: https://orcid.org/0000-0002-3633-0955)
- Nicholas Hanuscheck (ORCID: https://orcid.org/0000-0003-1166-6273)
- Clemens Warnke (ORCID: https://orcid.org/0000-0002-3510-9255)
- Florian Then Bergh (ORCID: https://orcid.org/0000-0001-8604-8408)
- Marc Pawlitzki (ORCID: https://orcid.org/0000-0003-3080-2277)
- Muriel Schraad
- Frauke Zipp (ORCID: https://orcid.org/0000-0002-1231-1928)
- Katrin Pape (ORCID: https://orcid.org/0000-0001-9211-5873)
- Josef Shin (ORCID: https://orcid.org/0000-0002-3556-125X)
- Antonios Bayas (ORCID: https://orcid.org/0000-0002-7418-9040)
- Vinzenz Fleischer (ORCID: https://orcid.org/0000-0002-3293-5121)
- Martin S. Weber (ORCID: https://orcid.org/0000-0001-8409-0389)
- Ralf A. Linker (ORCID: https://orcid.org/0000-0002-8740-3106)
- Mathias Mäurer
- Ralf Gold
- Sven G. Meuth
Institutions
- The University of Sydney (AU)
- University of Augsburg (DE)
- Johannes Gutenberg University Mainz (DE)
- Heidelberg University (DE)
- University Medical Center Freiburg (DE)
- University Hospital Heidelberg (DE)
- University Hospital Regensburg (DE)
- Medizinische Hochschule Hannover (DE)
- Düsseldorf University Hospital (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- University Hospital Münster (DE)
- Fraunhofer Institute for Translational Medicine and Pharmacology (DE)
- Munich Cluster for Systems Neurology (DE)
- University Hospital Leipzig (DE)
- St. Josef-Hospital (DE)
- University and Rehabilitation Clinics Ulm (DE)
- Institute of Neuroimmunology of the Slovak Academy of Sciences (SK)
- Klinikum Würzburg Mitte (DE)
- University Hospital Cologne (DE)
- Heinrich Heine University Düsseldorf (DE)
- University of Rostock (DE)
- Technical University of Munich (DE)
- Palacký University Olomouc (CZ)
- University of Göttingen (DE)
- Ludwig-Maximilians-Universität München (DE)
- Ruhr University Bochum (DE)
- Leipzig University (DE)
Publication Details
- Journal
- Therapeutic Advances in Neurological Disorders
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17562864251396006
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47